PA
APOG icon

PharVision Advisers’s Apogee Enterprises APOG Stock Holding History

PharVision Advisers’s Portfolio APOG Stock Details APOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,220
Closed -$226K – 128
2025
Q4 		$226K Buy
+6,220
New +$235K 0.11% 457
2025
Q2 		– Sell
-5,786
Closed -$268K – 274
2025
Q1 		$268K Buy
+5,786
New +$295K 0.37% 119

Other funds holding APOG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

PharVision Advisers's APOG Position: Q1 2026 in Review

PharVision Advisers sold out of Apogee Enterprises (APOG) in Q1 2026, closing a stake of 6,220 shares — an estimated $226K sold.

PharVision Advisers first reported a position in APOG in Q1 2025 and held it in 2 quarters. The position peaked at $268K in Q1 2025. 220 funds tracked by Wall St. Rank hold APOG as of Q1 2026.

  • PharVision Advisers reported no remaining Apogee Enterprises position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 6,220 Apogee Enterprises shares in Q1 2026, an estimated $226K.
  • PharVision Advisers first reported a position in Apogee Enterprises in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's Apogee Enterprises position peaked at $268K in Q1 2025.
  • 220 funds tracked by Wall St. Rank held Apogee Enterprises as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.